Biomedica Foscama is a long established Italian pharmaceutical company since 1947.
It is an international company supplying more than 15 markets worldwide (including CIS, China and Far East countries). It is a flexible company ready to adapt its production capacity to the market and to the customers’ needs.
Foundation of the company from the union of Biomedica International and Foscama
Launch in Italy of Hexaphosphine (fructose-1,6-diphosphate)
Launch of TAD (glutathione) in Italy
Acquisition by auction of the site from SPL
Complete revamping to reactivate the site
certificate for finished dosage form
GMP certificate for API
New injectable vials area with tunnel, autoclave for terminal sterilization.
New freeze-drying area to increase current production capacity
New area dedicated to vaccines and high containment products
Biomedica Foscama is able to sustain the entire value chain: from raw material to finished product.
Flexibility and ability to expand capacity in a modular way
Biomedica Foscama is able to meet specific needs thanks to dynamism, reliability and production modularity.
Ahead of changes
Thanks to its long-term entrepreneurial vision, Biomedica Foscama anticipates changes in the industry and invests in cutting-edge solutions, also looking at new markets.
Biomedica Foscama boasts true operational excellence and pursues a company policy aimed at continuous and ambitious improvement.
The ideal partner for the development and manufacturing of sterile products